162 related articles for article (PubMed ID: 12180283)
1. [Physiopathology of HCV infection].
Zarski JP; Souvignet C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B154-62. PubMed ID: 12180283
[No Abstract] [Full Text] [Related]
2. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immune responses in acute and chronic hepatitis C virus infection.
Bowen DG; Walker CM
Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
[TBL] [Abstract][Full Text] [Related]
4. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of hepatitis C virus infection and related liver disease.
Pawlotsky JM
Trends Microbiol; 2004 Feb; 12(2):96-102. PubMed ID: 15036326
[TBL] [Abstract][Full Text] [Related]
6. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
7. [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
Thimme R; Spangenberg HC; Von Weizsäcker F; Blum HE
Dtsch Med Wochenschr; 2002 Oct; 127(43):2277-9. PubMed ID: 12397543
[No Abstract] [Full Text] [Related]
8. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
[TBL] [Abstract][Full Text] [Related]
9. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
Kanno A; Kazuyama Y
J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
[TBL] [Abstract][Full Text] [Related]
12. Natural history of acute symptomatic hepatitis type C.
Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
[TBL] [Abstract][Full Text] [Related]
13. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
Kowala-Piaskowska A
Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
[TBL] [Abstract][Full Text] [Related]
17. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
[TBL] [Abstract][Full Text] [Related]
18. Biomedicines to reduce inflammation but not viral load in chronic HCV--what's the sense?
Chuang E; Del Vecchio A; Smolinski S; Song XY; Sarisky RT
Trends Biotechnol; 2004 Oct; 22(10):517-23. PubMed ID: 15450745
[TBL] [Abstract][Full Text] [Related]
19. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
20. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
